SEATTLE, July 26, 2021, (MEDGADGET) — Global Biologics Market – Insights
A biologic medicine (biologic) is a medication made from living organisms or containing living organism components. For the manufacture of new biologics, new innovations and experimental treatments are evolving, indicating that the global biologics industry has a bright future. A number of illnesses, including autoimmune disorders, cancer, infectious diseases, and chronic kidney disease, are treated with biologics.
In 2019, the global biologics market is projected to be worth US$ 255.19 billion, with a CAGR of 7.6% expected over the forecast period (2019-2027).
Get Sample PDF Brochure with Impact of COVID19: https://www.coherentmarketinsights.com/insight/request-pdf/2663
The global biologics market is expected to rise due to an expanding pipeline of biologics:
A variety of biopharmaceuticals drugs are in clinical trials and are expected to gain approval in the near future. As a result, the global biologics market is projected to expand significantly over the forecast period due to a strong pipeline of biopharmaceutical products. Monoclonal antibodies AMG 820 and AMG 966, for example, are in phase I clinical trials; monoclonal antibodies AMG 301, AMG 557, AMG 714, and Tezepelumab are in phase II clinical trials; and monoclonal antibodies Aimovig (erenumab), EVENTIYTM (romosozumab), Tezepelumab, and Prolia (denosumab) are in phase III
Furthermore, Novartis International AG, a Swiss pharmaceutical firm, has a pipeline full of monoclonal antibodies. In phase III clinical trials, the company has monoclonal antibodies Xolair, Cosentyx, OMB157, RTH258, and Lucentis; monoclonal antibodies QGE031 and BYM338 are in phase II clinical trials.
Restraints:
However, due to high costs and a lack of reimbursement for biologics, middle-to-low-income economies such as India, Indonesia, Bangladesh, Mexico, Brazil, and some European countries have insufficient access to biologics. As a result, the biologics market is projected to be hampered by lower availability and affordability of biologics in middle and lower income countries over the forecast period. For example, according to the article ‘Affordability Issues of Biotech Drugs in Low- and Middle-Income Countries (LMICs)’ published in Drug Designing and Intellectual Properties International Journal 2019, 63 million people in India are forced into poverty every year due to extremely high health costs, the majority of which are out-of-pocket payments for medicines.
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Exclusive offer!!! Purchase the report at a discounted rate!!!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Flat Instant discount of US$ 2000
Buy Now with Discount for Premium Report 2021: https://www.coherentmarketinsights.com/promo/buynow/2663
Regional Insights:
On the basis of region, the global biologics market is segmented into Latin America, Europe, Asia Pacific, North America, Africa, and Middle East. Because of the increasing number of biologics drug approvals by regulatory authorities, North America is expected to maintain a dominant place in the global biologics market over the forecast period. For example, the FDA approved GlaxoSmithKline’s biologic Nucala in 2017 for the treatment of eosinophilic granulomatosis with polyangiitis, a rare disease (EPGA).
Because of the rising prevalence of diabetes in this area, Asia Pacific is expected to be the fastest growing region in the global biologics market. According to the International Diabetes Federation (IDF) Diabetes Atlas: 2017, the number of people with diabetes aged 20 to 79 years in the South East Asia and Western Pacific regions in 2017 was 82 million and 159 million, respectively, according to the International Diabetes Federation (IDF).
View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/biologics-market-3010
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Therapeutic Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Biologics & Biosimilars Overview
- Impact Analysis
- Patent Expiry Analysis
- Pipeline Analysis
- Regulatory Scenario
- Reimbursement Scenario
- Product Approval/Launch
- Collaboration-Acquisition
- Market Trends
- PEST Analysis
- Epidemiology
- Market Dynamics
- Global Biologics Market, By Drug Class, 2019 – 2027, (US$ Billion)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Monoclonal Antibody
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Billion)
- Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Billion)
- Recombinant Insulin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Billion)
- Human Growth Hormone
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Billion)
- Blood Factor
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Billion)
- Fusion Protein
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Billion)
- Erythropoietin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Billion)
- Interferon
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Billion)
- Recombinant Enzyme
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Billion)
- Colony-stimulating Factor
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Billion)
- Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Billion)
- Gene Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Billion)
- Oligonucleotides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Billion)
- Others (Peptide, Botulinum Toxin, and Others)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Billion)
- Introduction
- Global Biologics Market, By Therapeutic Application, 2019 – 2027, (US$ Billion)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Billion)
- Metabolic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Billion)
- Autoimmune/Immunologic Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Billion)
- Ophthalmic Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Billion)
- Inflammatory Bowel Diseases (IBDs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Billion)
- Respiratory Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Billion)
- Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Billion)
- Musculoskeletal Disorders (MSDs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Billion)
- Cardiovascular Diseases (CVDs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Billion)
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Billion)
- Introduction
- Global Biologics Market, By Distribution Channel, 2019 – 2027, (US$ Billion)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Billion)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Billion)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Billion)
- Introduction
- Global Biologics Market, By Region, 2019 – 2027 (US$ Billion)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Regional Trends
- North America
- Market Size and Forecast, By Drug Class, 2016 – 2027, (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2016 – 2027, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Billion)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Billion)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Drug Class, 2016 – 2027, (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2016 – 2027, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Billion)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Drug Class, 2016 – 2027, (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2016 – 2027, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Billion)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Billion)
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast, By Drug Class, 2016 – 2027, (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2016 – 2027, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Billion)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Africa
- Market Size and Forecast, By Drug Class, 2016 – 2027, (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2016 – 2027, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Billion)
- Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Billion)
- North Africa
- Central Africa
- South Africa
- Middle East
- Market Size and Forecast, By Drug Class, 2016 – 2027, (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2016 – 2027, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Billion)
- Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Billion)
- GCC
- Israel
- Rest of Middle East
- Introduction
- Competitive Landscape
- Company Profiles
- Section
- References
- Research Methodology
- About Us and Sales Contact
Have a Look at Related Research Insights:
Plant-Based Biologics Market To Surpass US$ 24.9 Million By 2027
U.S. Non-Oncology Biopharmaceuticals Market To Surpass US$ 253.0 Bn Threshold By 2026
MENA Biologics & Biosimilars Market To Surpass US$ 623.7 Million By 2027
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837